血液系统

  • 网络Hematologic;The Blood System
血液系统血液系统
  1. 参麦注射液对~(60)Co照射小鼠血液系统作用的研究

    The effect of Shenmai injection on the blood system of ~ ( 60 ) Co irradiated mice

  2. 目的:探讨小儿血液系统常见疾病的骨髓MRI表现。

    Purpose : To evaluate MRI manifestation of bone marrow for the common diseases of the blood system in children .

  3. Toll样受体和血液系统恶性肿瘤的研究进展

    Toll like receptors and hematologic malignancies : recent progress

  4. 目的:探讨维生素C、维生素E对染铅大鼠血液系统和海马组织的保护作用及机理。

    Objective : To study the effect and mechanism of VitC , VitE on the blood system and hippocampus of lead poisoning SD rats .

  5. 5-HT3受体拮抗剂在血液系统恶性肿瘤患者化疗止吐中的应用

    The application 5-HT_3 antagonist in anti-vomiting treatment for hemato-logic neoplasms chemotherapy

  6. 结论:MRI对小儿血液系统疾病骨髓改变的评价有意义。

    Conclusion : MRI plays an important role in the evaluation of bone marrow character of blood system disease in children .

  7. 血液系统肿瘤中WT1基因突变及启动子区域DNA甲基化的研究

    Study on WT1 Gene Mutation and Its Promoter Region DNA Methylation Status in Hematology Neoplasms

  8. 硝基化和氧化相关酶类iNOS和COX-2与血液系统恶性肿瘤

    Relationship between nitration and oxidation related enzymes iNOS , COX-2 and hematological malignancies

  9. SLE患者血液系统异常(附113例分析)

    Abnormalities of Blood System in Patients with SLE ( Analysis of 113 Cases )

  10. 顺铂对小鼠血液系统具有毒副作用,而组织中金属硫蛋白(MT)的产生能减轻其毒性反应。

    Cisplatin can cause hematological toxicity which can be reduced by tissue metallothionein ( MT ) .

  11. 结论EGFR基因的扩增与重排较少发生在人类血液系统恶性疾患中。

    Conclusion 1.EGFR gene amplification and rearrangement rarely occur in human malignant hematologic disorders .

  12. 造血干细胞中G-CSF信号通路持续过度激活可导致血液系统肿瘤的发生。

    Persistent activation of G-CSF signaling induces tumor formation in hematopoietic system .

  13. 血液系统损害男女发生率分别为80%、69.67%,差异无显著性(P0.05)。

    The blood system damage in male and female rates were 80 % , 69.67 % , difference was not significant ( P0.05 ) .

  14. 血液系统损害汉族、少数民族发生率分别为70.59%、69.81%,发生率无明显差异(P0.05)。

    Of the blood system damage in Han nationality , ethnic minority rates were 70.59 % , 69.81 % , There was no significant difference .

  15. 血液系统肿瘤更易发生B19感染;

    Patients with blood system tumors are more prone to B19 infection .

  16. CIK细胞在恶性血液系统疾病中的应用研究

    Application of CIK cells to malignant hematological disease

  17. CD59抗原在血液系统恶性肿瘤患者中的表达及意义

    Expression of CD59 antigen from patients with haematological malignancies and its clinical significance

  18. 目的探索长期接触低剂量X射线对医务人员血液系统及其遗传物质的影响,为当前放射医务人员的卫生防护工作提供依据。

    Objective To explore the effect of long-term low-dose X-ray on the blood system and genetic material in the health workers and to provide basis for protecting the radiological health workers .

  19. 方法:采用PCR-SSCP方法对34例血液系统肿瘤患者p53基因第5、8外显子进行研究。

    Method : Exon 5 、 8 of the p53 gene were scanned in 34 cases of hematologic malignancies by PCR SSCP .

  20. 儿童、中青年、老年血液系统损害发生率分别为71.43%、70.43%、70.59%,三者之间无明显差异(P0.05)。

    Children , middle-aged , older blood system damage rates were 71.43 % , 70.43 % , 70.59 % , no significant difference between the three ( P0.05 ) .

  21. 针对NOS、COX或两者的选择性抑制剂为血液系统恶性肿瘤的治疗提供了新的线索。

    The selective inhibitors of NOS , COX , or the both may provide a new approach for the treatment of hematological malignancies .

  22. 目的:为研究EGFR在血液系统疾病中的表达情况,并探讨EGFR表达与恶性血液病的关系。

    Objective : To study the expression of EGFR in hematologic diseases and the relationship between EGFR expression and malignant hematologic diseases .

  23. 非血液系统毒性研究组和对照组的恶心呕吐发生率分别为27.3%和61.9%,两组比较有统计学意义(P0.05)。

    Non-hematologic toxicity test group and control group of nausea and vomiting incidence were 27.3 % and 61.9 % , compared the two groups has statistical significance ( P0.05 ) .

  24. 在血液系统中以N-ras的表达为主。

    In blood system , N - ras is the most important .

  25. 目的探讨甲泼尼松龙冲击和常规剂量强的松治疗系统性红斑狼疮(SLE)血液系统损害的近期疗效。

    Objective To explore methylprednisolone and conventional dose prednisone treatment for hematological damage in systemic lupus erythematosus ( SLE ) in the near future response .

  26. 结论:接受化疗的血液系统恶性肿瘤病人仍保留了对rhG-CSF的部分正常反应。

    Conclusions : The patients with hematological malignancies having undergone chemotherapy have a partially normal response to rhG-CSF .

  27. 目的探讨CD59抗原在血液系统恶性肿瘤患者红细胞及成熟粒细胞上的表达及意义。

    Objective To explore the expression of CD59 antigen from patients with haematological malignancies and its clinical significance .

  28. 研究MSC与造血作用的关系及其机理,在血液系统疾病的临床实践中具有广阔的应用前景。

    The author believes that the research on the relationship between MSC and hematopoiesis brings wider practical prospect in the clinic disease application of blood .

  29. 2)DNA损伤和修复的动力学改变在器官间存在较大的差异,DNA损伤明显且修复较慢的器官或组织(肺、胃和血液系统)与其致癌的靶器官有较好的一致性。

    B ) DNA damage and repair dynamics were obviously different among the test organs , and the organs with DNA damage and slow repaired ( lung , stomach and hemocyte ) were in accordance with the carcinogenic targets .

  30. MicroRNA与血液系统肿瘤发生、诊断和治疗飞行人员甲状腺肿瘤20例诊治分析

    Role of microRNA in hematological malignancies THE DIAGNOSIS AND TREATMENT OF ANALYSIS PILOTS THYROID CANCER OF 20 CASES